Background and purpose The risk of developing cognitive decline had been observed to be
higher in patients with Parkinson's disease (PD) compared to the healthy controls at the …

The early detection of cognitive decline in Parkinson's disease is important for providing
drug therapy and non-pharmacological management. The circulating microRNAs present in …

Early detection of cognitive decline and in-time non-pharmacological management or drug
therapy are extremely important in providing care for Parkinson's disease with dementia …

Context: Sensitive, non-invasive biomarkers that facilitate Parkinson's disease (PD)
detection and stage assignment are currently unavailable. Objective: The objective of this …

Abstract Background & Objective: Circulating microRNAs (miRNAs) expressions have
been suggested as potential biomarkers for Parkinson's Disease (PD). Identification of early …

Blood circulating microRNAs (miRNAs) are proposed to be promising biomarkers for many
neurodegenerative disorders, including Parkinson's disease (PD). However, there is a lack …

Background and objective Parkinson's disease (PD) is the second most common age-
related neurodegenerative disorder after Alzheimer's disease. The aim of this work was to …

Objective: The goal of this study was to compare the microRNA (miRNA) profile of
Parkinson's disease (PD) frontal cortex with normal control brain, allowing for the …

The deregulation of several microRNAs (miRNAs) has been associated with
neurodegenerative processes, including Parkinson's disease (PD). Our aim was to …

Parkinson's disease (PD) is the second most common neurodegenerative disease. One of
the major challenges in studying this progressive neurological disorder is to identify and …